These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30102895)

  • 1. Bumetanide attenuates acute lung injury by suppressing macrophage activation.
    Hung CM; Peng CK; Wu CP; Huang KL
    Biochem Pharmacol; 2018 Oct; 156():60-67. PubMed ID: 30102895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NKCC1 Modulates Alveolar Fluid Clearance and Inflammation in Ischemia-Reperfusion Lung Injury via TRAF6-Mediated Pathways.
    Shen CH; Lin JY; Chang YL; Wu SY; Peng CK; Wu CP; Huang KL
    Front Immunol; 2018; 9():2049. PubMed ID: 30271405
    [No Abstract]   [Full Text] [Related]  

  • 3. WNK4-SPAK modulates lipopolysaccharide-induced macrophage activation.
    Hung CM; Peng CK; Yang SS; Shui HA; Huang KL
    Biochem Pharmacol; 2020 Jan; 171():113738. PubMed ID: 31786261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Hyperglycemia Aggravates Lung Injury via Activation of the SGK1-NKCC1 Pathway.
    Wu CP; Huang KL; Peng CK; Lan CC
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na
    Zheng LF; Ji T; Guo ZH; Wang T; Xiu XL; Liu XY; Li SC; Sun L; Xue H; Zhang Y; Zhu JX
    Eur J Pharmacol; 2020 Aug; 880():173162. PubMed ID: 32423868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Na
    Zhang J; Pu H; Zhang H; Wei Z; Jiang X; Xu M; Zhang L; Zhang W; Liu J; Meng H; Stetler RA; Sun D; Chen J; Gao Y; Chen L
    Neurochem Int; 2017 Dec; 111():23-31. PubMed ID: 28577991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B.
    Hampel P; Römermann K; MacAulay N; Löscher W
    Sci Rep; 2018 Jun; 8(1):9877. PubMed ID: 29959396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Na-K-Cl cotransporter isoform 1 reduces lung injury induced by ischemia-reperfusion.
    Lan CC; Peng CK; Tang SE; Lin HJ; Yang SS; Wu CP; Huang KL
    J Thorac Cardiovasc Surg; 2017 Jan; 153(1):206-215. PubMed ID: 27986254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloride cotransporter NKCC1 inhibitor bumetanide protects against white matter injury in a rodent model of periventricular leukomalacia.
    Jantzie LL; Hu MY; Park HK; Jackson MC; Yu J; Maxwell JR; Jensen FE
    Pediatr Res; 2015 Apr; 77(4):554-62. PubMed ID: 25585037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A.
    Lykke K; Töllner K; Feit PW; Erker T; MacAulay N; Löscher W
    Epilepsy Behav; 2016 Jun; 59():42-9. PubMed ID: 27088517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants and NOS inhibitors selectively targets manganese-induced cell volume via Na-K-Cl cotransporter-1 in astrocytes.
    Alahmari KA; Prabhakaran H; Prabhakaran K; Chandramoorthy HC; Ramugounder R
    Brain Res; 2015 Jun; 1610():69-79. PubMed ID: 25817889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Slc12a1 expression in β-cells and improved glucose disposal in Slc12a2 heterozygous mice.
    Alshahrani S; Almutairi MM; Kursan S; Dias-Junior E; Almiahuob MM; Aguilar-Bryan L; Di Fulvio M
    J Endocrinol; 2015 Dec; 227(3):153-65. PubMed ID: 26400961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacological inactivation of apical Na
    Gregoriades JMC; Madaris A; Alvarez FJ; Alvarez-Leefmans FJ
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C525-C544. PubMed ID: 30576237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKCC1 Inhibition Attenuates Chronic Cerebral Hypoperfusion-Induced White Matter Lesions by Enhancing Progenitor Cells of Oligodendrocyte Proliferation.
    Yu Y; Fu P; Yu Z; Xie M; Wang W; Luo X
    J Mol Neurosci; 2018 Mar; 64(3):449-458. PubMed ID: 29502291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
    Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
    Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
    Panet R; Marcus M; Atlan H
    J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous extract of Descuraniae Semen attenuates lipopolysaccharide-induced inflammation by inhibiting ER stress and WNK4-SPAK-NKCC1 pathway.
    Hsieh PC; Huang KL; Peng CK; Wu YK; Liu GT; Kuo CY; Wang MC; Lan CC
    J Cell Mol Med; 2024 Aug; 28(15):e18589. PubMed ID: 39135202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bumetanide-induced NKCC1 inhibition attenuates oxygen-glucose deprivation-induced decrease in proliferative activity and cell cycle progression arrest in cultured OPCs via p-38 MAPKs.
    Fu P; Tang R; Yu Z; Huang S; Xie M; Luo X; Wang W
    Brain Res; 2015 Jul; 1613():110-9. PubMed ID: 25881895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Na(+)-K(+)-2Cl(-) Cotransporter-1 attenuates traumatic brain injury-induced neuronal apoptosis via regulation of Erk signaling.
    Hui H; Rao W; Zhang L; Xie Z; Peng C; Su N; Wang K; Wang L; Luo P; Hao YL; Zhang S; Fei Z
    Neurochem Int; 2016 Mar; 94():23-31. PubMed ID: 26854573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
    Hampel P; Römermann K; Gailus B; Johne M; Gericke B; Kaczmarek E; Löscher W
    Neuropharmacology; 2021 Mar; 185():108449. PubMed ID: 33450274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.